Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma.

Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma.

Item
http://www.wikidata.org/entity/Q33378128
Metronomic oral cyclosphosphamide as third-line systemic treatment or beyond in patients with inoperable locoregionally advanced recurrent or metastatic nasopharyngeal carcinoma.Phase II trial of capecitabine plus cisplatin as first-line therapy in patients with metastatic nasopharyngeal cancer.Triplet combination with paclitaxel, cisplatin and 5-FU is effective in metastatic and/or recurrent nasopharyngeal carcinoma.Treatment outcome of docetaxel, capecitabine and cisplatin regimen for patients with refractory and relapsed nasopharyngeal carcinoma who failed previous platinum-based chemotherapy.Phase II trial of docetaxel combined with nedaplatin for patients with recurrent and metastatic nasopharyngeal carcinomaMulti-institutional prospective study of nedaplatin plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens.Role of plasma EBV DNA levels in predicting recurrence of nasopharyngeal carcinoma in a Western population.Development of a ten-signature classifier using a support vector machine integrated approach to subdivide the M1 stage into M1a and M1b stages of nasopharyngeal carcinoma with synchronous metastases to better predict patients' survivalMale breast metastases from nasopharyngeal carcinoma: A case report and literature review.Radiation recall after capecitabine in a patient with recurrent nasopharyngeal carcinoma: a case report.Combined CT-guided radiofrequency ablation with systemic chemotherapy improves the survival for nasopharyngeal carcinoma with oligometastasis in liver: Propensity score matching analysis.Plasma Epstein-Barr virus DNA level strongly predicts survival in metastatic/recurrent nasopharyngeal carcinoma treated with palliative chemotherapy.Neoadjuvant Chemotherapy With Capecitabine Plus Cisplatin in Patients With Locally Advanced Nasopharyngeal Cancer: Case Series Study.Systemic therapies for recurrent or metastatic nasopharyngeal carcinoma: a systematic review.Pharmacokinetic and Pharmacodynamic Analyses of 5-Fluorouracil in East-Asian Patients with Nasopharyngeal Carcinoma.
P2860

Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma.

Item
http://www.wikidata.org/entity/Q33378128
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Phase II study of capecitabine ...... atic nasopharyngeal carcinoma.
@ast
Phase II study of capecitabine ...... atic nasopharyngeal carcinoma.
@en
type
label
Phase II study of capecitabine ...... atic nasopharyngeal carcinoma.
@ast
Phase II study of capecitabine ...... atic nasopharyngeal carcinoma.
@en
prefLabel
Phase II study of capecitabine ...... atic nasopharyngeal carcinoma.
@ast
Phase II study of capecitabine ...... atic nasopharyngeal carcinoma.
@en
P1433
P1476
P2093
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P921
P356
P1433
P1476
Phase II study of capecitabine ...... atic nasopharyngeal carcinoma.
@en
P2093
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P921